Tandem Health

Name: Tandem Health
Brand: Tandem Health
Rating: 4.7 (5 reviews)

AI Native

Tandem Health is a clinical AI platform that captures consultation audio, generates transcripts and structured draft clinical notes, suggests clinical codes, and enables single-step transfer of approved documentation into EHR/EMR systems.

Est 2023|66 Ref Customers

LinkedIn 32K|Web traffic 100K|FTEs 170|HQ Stockholm, Sweden

Published Oct 15, 2026

01Common complaints

- Company sizes or stages where this product is overkill or insufficient - Solo or very small practices that want self-serve, low-cost tools and can tolerate copy/paste workflows may find Tandem’s enterprise/compliance posture unnecessary. - Industries or use cases where competitors are clearly superior - US-first healthcare organizations that require explicit HIPAA/BAA plus SOC 2 Type II may prefer vendors with clear US compliance packaging. - Technical requirements that this product cannot meet - Environments that prohibit browser extensions or have locked-down desktops may struggle if Tandem’s transfer workflow relies heavily on a browser extension. - Budget constraints that make alternatives more appropriate - If per-seat costs and implementation services are high, some clinics may choose tools with free tiers or lower-cost monthly plans. - Specific workflows or integrations where the product falls short - If a specific EHR is not among Tandem’s claimed 100+ supported systems, the single-step transfer value proposition may collapse into manual work. - Red flags in the buying process - If pricing is only available via sales and requires annual contracts, some buyers may prefer vendors with transparent monthly pricing. - Current limitations acknowledged by the vendor - Terms of Service indicates Tandem should not be used to generate medical diagnoses or treatment recommendations (limits copilot-like expectations). - Features on the roadmap (not yet available) - note estimated dates if available - Release notes indicate expansion beyond scribing; Clinical Decision Support is listed as available to select customers and is described as CE marked under EU MDR Class IIa in company release notes. - Scale limitations (at what volume/size does it break down?) - Not publicly documented. - Security or compliance gaps - SOC 2 Type II and several common enterprise artifacts were not clearly found in publicly accessible sources; confirm during procurement. - Technical debt or architectural limitations mentioned in reviews - Not found. - API limitations or integration constraints - Tandem emphasizes EHR transfer and a browser extension; API availability and limits were not clearly documented in the sources reviewed.

Deal disqualifiers: what makes a POOR fit

Strict requirement for SOC 2 Type II and HIPAA/BAA with US-centric legal terms (unless Tandem provides these artifacts)
Need for fully EHR-embedded note generation with no browser extension
Use cases where clinicians cannot reliably review notes (high error cost, low review time)

Why some customers left for competitors (churn reasons)

Not clearly documented in accessible sources for Tandem specifically.
Likely churn drivers in this category (industry-wide)
- Note quality variance by specialty or accent/language
- Integration gaps with a specific EHR
- Pricing changes or seat minimums
- Unresolved clinical governance concerns

02Why they buy

- Competitive advantages validated by customer feedback (not just vendor claims) - Public, independent validation was limited due to sparse accessible reviews; treat unique selling point claims as vendor-led unless verified in pilots. - Unique features and capabilities competitors lack - Tandem emphasizes broad EHR transfer support (a claimed 100+ systems) and structured single-step transfer. - Differentiation from competitors based on reviews - Not enough Tandem-specific review content was accessible to confidently attribute differentiation based on independent reviews. - Value propositions with evidence from case studies - Tandem references large-scale note generation (375,000 notes) and impact claims on its site; evaluate the underlying publication for design and reproducibility. - Areas where competitors clearly have advantages (be balanced) - Competitors like Heidi market evidence/citation tooling and broad document generation as differentiators. - Some vendors may be more transparent on US compliance artifacts.

Why customers chose this product over alternatives

Likely differentiators implied by vendor positioning
- Europe-focused compliance posture (GDPR, ISO 27001, ISO 13485, NHS DSPT messaging).
- Vendor-claimed broad EHR transfer coverage (many systems) and emphasis on structured content transfer rather than copy/paste.

03Field reports

Direct quotes from Gartner Peer Insights, Reddit, TrustRadius, G2, HackerNews

- Gartner Peer Insights - Attempted but inaccessible for product-specific Tandem Health reviews in the automated session. Only generic Gartner Peer Insights pages were accessible; no Tandem Health listing/review content was obtained. - G2 (Tandem Health “Tandem”) - Rating snapshot: a high rating shown on the vendor listing from a very small review sample (interpret cautiously). - Vendor-claimed outcomes on the listing include a claim of per-clinician time savings and a claim of a large installed base of healthcare organisations using Tandem (claims should be validated during procurement). - Reddit - Important caveat: Many “Tandem” Reddit results refer to Tandem Diabetes Care (insulin pumps), not Tandem Health (AI scribe). Those are not applicable to evaluating Tandem Health. - Broader AI scribe community discussions show common consent/privacy concerns. For example, a Reddit user described learning after the fact that a physician used an AI scribe and expressed frustration about lack of upfront notice/consent (general AI scribe concern, not Tandem-specific). - Hacker News - HN discussion located was about the general concept “Patients need an AI scribe of their own,” not Tandem specifically; it is useful for understanding market sentiment and patient-side concerns rather than vendor evaluation. - TrustRadius - Attempted to find Tandem Health-specific TrustRadius reviews; accessible pages were TrustRadius home/about content, not a product page for Tandem Health.

Balance: Include both high and low reviews

Limitation
- Publicly accessible review content for Tandem Health was limited in this research session.
- G2 shows a very small review count; no very low-star reviews were visible in the captured snippet.
- As a result, this section relies more heavily on community- and industry-wide AI scribe complaints rather than Tandem-specific low-star reviews.

Common criticisms and complaints (support issues, bugs, missing features)

- From general AI scribe user discussions (not Tandem-specific) - Consent transparency and “surprise recording” concerns. - Risk of incorrect or distorted clinical notes requiring careful review. - Sensitivity concerns for certain topics (immigration status, mental health, trauma histories), with some clinicians reporting they pause scribes for parts of the visit. - Tandem-specific complaints were not well represented in accessible public forums during this run; procurement teams should request references and off-platform references (peer calls) from the vendor.

Specific outcomes customers achieved (with metrics when available)

Vendor-claimed metrics
- Vendor-claimed per-clinician time savings appear on the public listing (vendor-claimed).
- Vendor website references research and impact including a vendor-reported large number of notes generated in a European health system; these metrics are vendor-linked and should be validated by reviewing the underlying publication and methods.

Customer pain points and frustrations mentioned in reviews

Insufficient Tandem-specific negative review text was accessible.
Industry-wide recurring pain points (from community discourse)
- Trust, privacy, and data use policies
- Fear of models training on sensitive encounters
- Medico-legal accountability if a note is wrong

Deal-breakers and reasons customers didn't purchase

Common deal-breakers in ambient scribe procurement (and consistent with enterprise security trends)
- Lack of required assurance artifacts (SOC 2 Type II, pen tests, DPIA readiness)
- Unclear data residency
- Missing SSO/SCIM/audit logs
- No seamless integration into the buyer’s EHR workflow

Detailed customer success stories with metrics

Tandem’s homepage references a publication titled “Impact of an AI medical scribe after a large volume of notes generated across care levels in a European health system” (dated Dec 8, 2025 on the homepage).
A preprint on a public preprint server referencing Tandem’s AI medical scribe is listed as a preprint.

Specific results and quantified business impact

Vendor-claimed results often emphasize time saved; however, quantified ROI should be treated as context-dependent and validated against study methodology.

Implementation details and time to value

Not clearly documented publicly in a case study format in the accessible snippets.

Challenges faced during adoption and how they were resolved

Not clearly documented in accessible case-study detail.

Note when metrics are vendor-published without independent verification

Vendor-published metrics reporting a very large volume of notes generated and several hours of clinician time saved per day should be validated by reviewing the underlying study design and whether outcomes were self-reported, time-motion measured, or EHR-metadata-derived.

Note methodology gaps

Without full access to the publication text and methods in this session, methodology cannot be verified; treat reported impact metrics as directional.

Include mixed results - projects that struggled or failed when available

No public “failed deployment” case studies for Tandem were identified.
Independent research suggests human-written notes can outperform AI scribe outputs in some simulated evaluations, reinforcing the need for robust QA processes even when time-saving benefits are reported.

04Best fit

Company sizes: specific employee counts and revenue ranges

- Likely best fit - Multi-clinician clinics and mid-market to enterprise care organizations - Rough heuristic: organizations ranging from small multi-clinician groups up through large clinician cohorts where documentation time savings and standardization justify procurement overhead - Smaller practices - May still benefit, but often prefer lower-friction tools with transparent self-serve pricing and minimal IT requirements

Industries and verticals where adoption is strongest (with customer examples)

Tandem positions for care organizations across Europe and across healthcare specialties, implying broad applicability (primary care, outpatient specialty, hospital outpatient).

Roles and personas: decision makers AND end users

Decision makers
- CMIO, CIO, Chief Clinical Informatics, Compliance/DPO, Practice Owners, Operations Directors
End users
- Physicians, NPs/PAs, therapists (depending on documentation needs), clinical coders (where coding suggestions matter)

Pain points and challenges the product addresses

Clinician time spent on notes and EHR clerical work
Coding burden
Fragmentation across EHR systems and documentation workflows

Qualification criteria: what makes a GOOD fit

Strong need for EHR transfer automation (not just note generation)
Europe-focused regulatory posture required (GDPR, ISO certifications, NHS DSPT)
Willingness to implement governance and review processes

Real customer examples with company names when available

Accurx Scribe is described as powered by Tandem in partner-facing documentation, indicating deployment in UK contexts via partner channels.

05The pitch

What the product does (core value proposition in objective terms)

- Tandem Health is a clinical AI platform intended to reduce clinician administrative work by capturing consultation audio, producing a transcript, generating structured draft notes, and proposing clinical codes for review. It also supports a single-step transfer of approved documentation into EHR/EMR systems. - Product modules/features repeatedly highlighted by Tandem include: - AI Scribe (ambient documentation) - Coding assistance (suggesting relevant clinical codes) - Clinical Decision Support (CDS) (newer capability; marketed as certified/regulated in the EU context)

Target market and market positioning

Primary users: clinicians and care teams in outpatient clinics and health systems (European focus). The company positions itself as a clinical AI platform rather than only a standalone scribe.
Messaging conveys a Europe-focused compliance posture (GDPR, ISO certifications, NHS requirements) and claims support for EHR transfer across many regional systems.

Get a comprehensive analysis of Tandem Health including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →